Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
复制标题
DOI:
10.1016/j.jvs.2008.11.001
复制
发表时间:
2009-03
影响因子:
4.3
通讯作者:
Haverich, Axel
中科院分区:
文献类型:
--
作者:
Kallenbach, Klaus;Salcher, Rolf;Heim, Albert;Karck, Matthias;Mignatti, Paolo;Haverich, Axel
Saphenous vein grafts suffer from neointima formation following bypass surgery. Matrix metalloproteinases (MMPs) play important roles in this process. We examined MMP-3 for its therapeutic potential to prevent smooth muscle cell migration and neointima formation in venous bypass grafts using adenovirus-mediated gene transfer. Human aortic smooth muscle cells (hAoSMC) were transduced with adenoviral vectors encoding β-galactosidase (Ad.βgal) or human MMP-3 (Ad.hMMP-3), and characterized for migration in the amniotic membrane stroma as an in vitro model of the vascular wall. Cholesterol-fed New Zealand White rabbits underwent jugular vein bypass grafting into carotid arteries. Before insertion, grafts were incubated ex vivo with either Ad.βgal or Ad.hMMP-3. Transgene expression was characterized by immunohistochemistry and in situ zymography. Grafts (n=6) were explanted after 28 days and intimal hyperplasia was quantified. Migration of hAoSMC was significantly reduced when transduced with Ad.hMMP-3 compared to controls (p<0.001). Immunocytochemistry of Ad.hMMP-3 transduced venous grafts localized this protein to the intima. In situ-zymography showed increased MMP activity in the intima of Ad.hMMP-3 transfected grafts. Stenosis degree (p=0,001), intima/media-ratio (p=0,023) and lesion thickness (p=0,003) were significantly reduced in grafts transduced with Ad.MMP-3 in comparison to controls. There was no difference inside control groups. MMP-3 overexpression inhibits formation of intimal hyperplasia in arterialized vein grafts. Adenovirus mediated gene transfer of MMP-3 may be of clinical use to prevent vein graft stenosis following bypass surgery.
登录
查看更多内容
影响因子:
15.9
作者:
GALIS, ZS;SUKHOVA, GK;LIBBY, P
通讯作者:
LIBBY, P
影响因子:
3.8
作者:
Fernandez, HA;Kallenbach, K;Galloway, AC
通讯作者:
Galloway, AC
DOI:
10.1073/pnas.0506201102
发表时间:
2005-10-25
影响因子:
11.1
作者:
Johnson, JL;George, SJ;Jackson, CL
通讯作者:
Jackson, CL
影响因子:
2
作者:
Lövdahl, C;Thyberg, J;Hultgårdh-Nilsson, A
通讯作者:
Hultgårdh-Nilsson, A
DOI:
10.1016/0735-1097(96)00206-9
发表时间:
1996-09-01
影响因子:
24
作者:
FitzGibbon, GM;Kafka, HP;Burton, JR
通讯作者:
Burton, JR